AARTIPHARM

Aarti Pharmalabs Ltd.

NSE: AARTIPHARM

BSE: 543748

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

855.50-23.6 (-2.68%)

9 Oct, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

46.7 / 100

Value Score

37.9 / 100

Price Momentum Score

76.1 / 100

QVM Score

53.9 / 100

Key Metrics

Market Cap

7757.67

P/E (TTM)

36.40

P/B

3.65

P/S (TTM)

3.94

EV/EBITDA

19.42

CAPE (5Y)

39.58

ROE (TTM)

8.49

ROCE (TTM)

11.19

ROA (TTM)

5.47

Avg 3Y ROE

12.04

Earnings 3Y CAGR

3.97

Sales 3Y CAGR

0.39

Sales 5Y CAGR

Debt/Equity

0.37

Consensus TP

740.00

Strong Buy %

Promoter Holding

42.86

Pledged %

11.08

Stock Analysis

Fundamental analysis overview of Aarti Pharmalabs Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 76.1 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

76.1 / 100

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.37 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.16 in the last 1 year

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 3 financial years

What is Dividend streak?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 36.4 indicates that the stock is expensive on a standalone basis and is at a 15.63% premium to industry median P/E

What is P/E Ratio?

Median: 31.48

Value 36.4

-0.8734.68

Low and declining ROE

The company reported low ROE of 8.49% for 12-month ended 30 Jun 2026 and ROE declined by -605 bps from 1 year ago

What is ROE (FY)?

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of 1.2% for 12-month ended 30 Jun 2026 and the growth was 9.48 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 10.68

Value 1.2

-99.6111701.8

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -20.04% for 12-month ended 30 Jun 2026 and the growth was 27.49 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.41%

What is Dividend yield?

Neutral

High operating margin but declining trend

The company reported strong operating margin of 16.67% for 12-month ended 30 Jun 2026 but operating margin declined by -252 bps from 1 year ago

What is Operating profit margin?

Company's earnings are of moderate quality

Earnings quality score of 57.4 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

57.4 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Aarti Pharmalabs Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Aarti Pharmalabs Ltd. Shareholding Pattern

Quarterly breakdown of Aarti Pharmalabs Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	45.98	45.98	46.30	46.46	46.46	46.46	46.10	44.66	44.29	43.72	42.88	43.10	43.08	42.86
Indian Promoter	45.81	45.81	46.13	46.29	46.29	46.29	45.93	44.48	44.12	43.55	42.71	42.93	42.91	42.69
Foreign Promoter	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17
Institutions	21.38	18.09	18.97	18.08	18.30	18.53	18.74	19.01	14.89	15.15	14.99	15.35	15.81	15.39
Mutual Funds / UTI	5.11	2.72	2.67	2.05	2.72	4.69	4.93	3.93	0.78	0.90	0.79	1.09	0.80	0.79
FI/Bank/Insurance	7.75	7.08	7.05	7.05	6.51	6.09	6.09	6.09	6.09	6.03	5.30	5.30	5.30	5.30
Govt	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
FII	7.69	7.43	8.45	8.17	8.33	7.07	7.38	8.64	7.36	7.34	8.02	7.68	8.39	8.17
Other Institutions	0.82	0.85	0.79	0.81	0.74	0.68	0.33	0.34	0.65	0.87	0.86	1.27	1.30	1.12
Non-Institution	32.64	35.93	34.73	35.46	35.23	35.00	35.16	36.33	40.82	41.12	42.13	41.54	41.11	41.75
Bodies Corporate	1.09	2.19	2.10	2.13	1.91	1.72	1.98	2.61	2.78	2.96	2.98	2.73	2.81	3.20
Others (incl. Retail) No. of shareholders	31.55 2,75,201	33.74 2,56,868	32.63 2,25,383	33.33 2,14,941	33.32 2,03,306	33.28 1,88,258	33.18 1,84,672	33.72 1,84,038	38.04 1,95,073	38.16 1,85,756	39.15 1,89,084	38.81 1,83,171	38.30 1,78,073	38.55 1,75,218

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	Nifty Microcap 250	0.55%	51 / 250
2	Nifty Total Market	0.02%	515 / 749

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Aarti Pharmalabs Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Relacion Trusteeship Services Private Limited Promoter Group	September-2026	Market Sale (Disposal) 22nd Sep 2026	0.69 %	₹ 818.79	6.28 lac	₹ 51.38 cr
Gloire Trusteeship Services Private Limited Promoter Group	September-2026	Market Sale (Disposal) 22nd Sep 2026	0.68 %	₹ 818.83	6.25 lac	₹ 51.14 cr
Safechem Enterprises Private Limited Promoter Group	July-2026	Market Sale (Disposal) 2nd Jul 2026	0.70 %	₹ 682.66	88.27 k	₹ 6.03 cr
Mirik Rajendra Gogri Promoter Group	March-2026	Market Sale (Disposal) 4th Mar 2026	1.15 %	₹ 705.73	9.00 k	₹ 63.52 lac
Narendra J Salvi KMP	December-2025	Market Sale (Disposal) 15th Dec 2025	0.01 %	₹ 722.11	3.00 k	₹ 21.66 lac
Hetal Gogri Gala Promoter Group	December-2025	Market Purchase (Acquisition) 5th Dec 2025	3.10 %	₹ 687.56	64.00	₹ 44.00 k
Hetal Gogri Gala Promoter Group	December-2025	Market Purchase (Acquisition) 4th Dec 2025	3.03 %	₹ 700.20	63.77 k	₹ 4.47 cr
Hetal Gogri Gala Promoter Group	December-2025	Market Purchase (Acquisition) 3rd Dec 2025	2.89 %	₹ 700.39	81.95 k	₹ 5.74 cr
Hetal Gogri Gala Promoter Group	December-2025	Market Purchase (Acquisition) 3rd Dec 2025	2.97 %	₹ 700.25	54.28 k	₹ 3.80 cr
Manjula M. Sangoi Directors Immediate Relative	September-2025	Market Sale (Disposal) 26th Sep 2025	0.02 %	₹ 881.24	5.00 k	₹ 44.06 lac

…

Corporate Actions

History of Aarti Pharmalabs Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 2/share
Record date: 15th Sep 2026Ex-date: 15th Sep 2026
Announced on: 25th May 2026
Dividend₹ 1.50/share
Record date: 16th Feb 2026Ex-date: 16th Feb 2026
Announced on: 9th Feb 2026
Dividend₹ 2.50/share
Record date: 15th Sep 2025Ex-date: 15th Sep 2025
Announced on: 11th May 2025
Dividend₹ 2.50/share
Record date: 14th Feb 2025Ex-date: 14th Feb 2025
Announced on: 5th Feb 2025
Dividend₹ 1/share
Record date: 31st Jul 2024Ex-date: 31st Jul 2024
Announced on: 13th May 2024

Company Profile

Overview of Aarti Pharmalabs Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Aarti Pharmalabs Limited is engaged in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, and xanthine derivatives. The Company also offers comprehensive contract development and manufacturing organization (CDMO) and CMO services for drug substances and new chemic...

Key personnel

Rakeshwar Bandichhor

Chief Scientific Officer - Research and Development

Mr. Jeevan Bhargav Mondkar

Company Secretary and Compliance Officer

Shri. Rashesh Chandrakant GogriD

Chairman of the Board, Managing Director

Smt. Hetal Gogri GalaD

Executive Vice Chairman of the Board

Mr. Chetan Bipin GandhiD

Director

Shri. Narendra Jagannath SalviD

Director

Shri. Parimal DesaiD

Non-Executive Director

Smt. Nehal GarewalD

Non-Executive Non-Independent Director

View all

Incorporated on

22 Nov 2019

Last Annual

31 Mar 2026

Last Interim

No. of Employees

2,421

IPO date

30 Jan 2023

Free Float

5,07,80,500

Website

https://www.aartipharmalabs.com/

Phone no.

+912269436100

Address

2nd Floor, 204, Udyog Kshetra, Mulund - Goregaon Link Rd, Mulund (W), MUMBAI, 400080, India

Frequently Asked Questions

What is the current share price of Aarti Pharmalabs Ltd.?

The current share price of Aarti Pharmalabs Ltd. is ₹ 855.50 as of 9 Oct 2026.

What is the market capitalisation of Aarti Pharmalabs Ltd.?

The market capitalisation of Aarti Pharmalabs Ltd. stands at ₹ 7,757.67 Cr.

What is the PE ratio of Aarti Pharmalabs Ltd.?

The Price-to-Earnings (PE) ratio of Aarti Pharmalabs Ltd. is 36.40 as of the latest trailing twelve months data.

What is the ROE and ROCE of Aarti Pharmalabs Ltd.?

Aarti Pharmalabs Ltd. has a Return on Equity (ROE) of 8.49% and a Return on Capital Employed (ROCE) of 11.19% as per the latest financial reports.

What is the 52-week high and low of Aarti Pharmalabs Ltd.?

The 52-week high of Aarti Pharmalabs Ltd. is - and the 52-week low is -.

What is the dividend yield of Aarti Pharmalabs Ltd.?

The dividend yield of Aarti Pharmalabs Ltd. is 0.41% based on the current market price.

What is the FII and DII holding in Aarti Pharmalabs Ltd.?

Foreign Institutional Investors (FII) hold 8.17%, Domestic Institutional Investors (DII) hold 6.09% and retail/public investors hold 38.55% of Aarti Pharmalabs Ltd. shares.

What sector does Aarti Pharmalabs Ltd. belong to?

Aarti Pharmalabs Ltd. operates in the Healthcare sector.

What is the beta of Aarti Pharmalabs Ltd.?

The beta of Aarti Pharmalabs Ltd. is 1.26, indicating its price volatility relative to the broader market. Over the past 1 year, Aarti Pharmalabs Ltd. has delivered an absolute return of 3.15%.

What is the RSI of Aarti Pharmalabs Ltd.?

The 14-day Relative Strength Index (RSI) of Aarti Pharmalabs Ltd. is 44.99, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Aarti Pharmalabs Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Aarti Pharmalabs Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Holdings and Presence

Corporate Actions

Company Profile